Companies / Lifecore Biomedical, Inc
Lifecore Biomedical, Inc
Nasdaq: LFCRCIK 1005286CHASKA, MN
Financials · FY2019
Ownership
37.9M shares outstanding · as of Jul 29, 2026
Ownership
| Insiders | 4.38% | 1,658,097 |
| 10%+ / strategic | 5.02% | 1,899,903 |
| Institutions | 60.84% | 23,030,849 |
| Public float | 29.76% | 11,264,211 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 16
View all →| Insider | % of shares | Shares |
|---|---|---|
Josephs PaulCEOChief Executive Officer · Director | 1.57% | 592,915 |
Salus Thomas D.Chief Legal & Administration | 0.65% | 246,333 |
Obus NelsonDirector | 0.43% | 164,100 |
Houde Lovas KatrinaDirector | 0.36% | 135,319 |
Schechter JoshuaDirector | 0.35% | 133,080 |
Kiper Christopher SDirector · 10% owner | 0.27% | 103,482 |
Antunes Humberto CalheirosDirector | 0.19% | 72,967 |
Aryeh JasonDirector | 0.18% | 69,967 |
Johnson Paul HaroldDirector | 0.18% | 69,967 |
Korenberg Matthew EDirector | 0.18% | 69,967 |
Institutional holders 105
View all →| Holder | Value | % of shares |
|---|---|---|
| $36.50M | 11.79% | |
| $30.12M | 9.73% | |
| $23.03M | <0.01% | |
| $17.69M | 5.71% | |
| $17.50M | 12.42% | |
| $13.69M | 4.42% | |
| $10.57M | 5.32% | |
| $6.15M | 1.99% | |
| $6.08M | 1.96% | |
| $3.62M | 1.17% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $556.5K | +106K +5.56% | 2,013,093 5.32% of shares | low |
| Q2 2026 as of | LPL Financial LLC 13F manager | Add | Common stock | $496.2K | +95K +83.79% | 207,300 0.55% of shares | low |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common stock | $433.9K | +83K +14.12% | 668,031 1.76% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | Trim | Common stock | $-351.7K | -95K -37.56% | 157,157 0.42% of shares | low |
| Q1 2026 as of | D. E. Shaw & Co., Inc. 13F manager | Exit | Common stock | $-306.2K | -37K -100.00% | 0 | low |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Exit | Common stock | $-227.4K | -28K -100.00% | 0 | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Trim | Common stock | $-194.4K | -52K -47.25% | 58,354 0.15% of shares | low |
| Q2 2025 as of | Barclays PLC 13F manager | Add | Common stock | $181.2K | +22K +87.69% | 47,775 0.13% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| BlackRock, Inc. | Passive13G | — |
| BlackRock, Inc. | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| LFCR | — | 514766104 |